Cloud Zoom small image
人IPSC来源神经干细胞(X-三体综合症)  英国Axol原装   ax1001

现价: 0.00
当前销售数量: 0


  • 产品描述
  • 产品特性
  • 评价

Human iPSC-Derived Neural Stem Cells - Trisomy X Patient. 1 vial of Neural Stem Cells (1.5 million cells/vial) and Neural Plating-XF Medium (30 mL).

Trisomy X (Triple X) syndrome occurs at a frequency of approximately 1 in 1000 newborn females. The syndrome is associated with an increased risk of seizures and may affect short-term memory and learning although the majority of women affected show few clinical symptoms. Axol has developed iPSC-derived neural stem cells from a patient with the triple X chromosomal abnormality. All of the iPS cells examined (20 individual cells karyotyped), had trisomy X.

Starting material Dermal fibroblast
Donor gender Female
Donor age at sampling 74 yrs
Karyotype Trisomy X (47, XXX)
Reprogramming method Episomal vector
Induction method Monolayer & chemically defined medium
Genetic modification None
Size ≥1.5 million cells
Cell type iPSC-derived neural stem cells
Growth properties Adherent
Shipping conditions Dry ice
Storage conditions Liquid nitrogen